Clinical Trial Update: Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis [Phase 3]

View source ↗

Summary

Open-label extension study evaluating zilucoplan for generalized myasthenia gravis is ongoing in Phase 3, with status active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• Zilucoplan (zilucoplan)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: ACTIVE_NOT_RECRUITING